Is There a Place for Ozone Therapy in Patients with Heart Failure?
Cardiovasc Toxicol
.
2017 Oct;17(4):496-497.
doi: 10.1007/s12012-017-9423-1.
Authors
Bernardino Clavo
1
2
3
,
Khaled Eltobgy
4
5
,
Eduardo Caballero
6
,
Cipriano Abad
7
,
Francisco Rodríguez-Esparragón
8
,
Norberto Santana-Rodríguez
8
9
Affiliations
1
Research Unit, Dr. Negrín University Hospital, 35019, Las Palmas, Canary Islands, Spain. bernardinoclavo@gmail.com.
2
Chronic Pain Unit, Dr. Negrín University Hospital, Las Palmas, Spain. bernardinoclavo@gmail.com.
3
Department of Radiation Oncology, Dr. Negrín University Hospital, Las Palmas, Spain. bernardinoclavo@gmail.com.
4
Medical Ozone Therapy Unit, Lekhwiya Medical Unit, Doha, Qatar.
5
Naval Hyperbaric Medical Institute, Alexandria, Egypt.
6
Cardiology, Dr. Negrín University Hospital, Las Palmas, Spain.
7
Cardiac Surgery, Dr. Negrín University Hospital, Las Palmas, Spain.
8
Research Unit, Dr. Negrín University Hospital, 35019, Las Palmas, Canary Islands, Spain.
9
Section of Thoracic Surgery, Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
PMID:
28853025
DOI:
10.1007/s12012-017-9423-1
No abstract available
Publication types
Comment
MeSH terms
Heart Failure*
Humans
Oxidative Stress / drug effects
Ozone*
Stroke Volume
Substances
Ozone